annual current liabilities:
$16.76B+$1.48B(+9.67%)Summary
- As of today (September 17, 2025), TAK annual total current liabilities is $16.76 billion, with the most recent change of +$1.48 billion (+9.67%) on March 1, 2025.
- During the last 3 years, TAK annual current liabilities has fallen by -$916.97 million (-5.19%).
- TAK annual current liabilities is now -27.33% below its all-time high of $23.07 billion, reached on March 31, 2019.
Performance
TAK Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$15.02B-$1.74B(-10.39%)Summary
- As of today (September 17, 2025), TAK quarterly total current liabilities is $15.02 billion, with the most recent change of -$1.74 billion (-10.39%) on June 1, 2025.
- Over the past year, TAK quarterly current liabilities has dropped by -$304.99 million (-1.99%).
- TAK quarterly current liabilities is now -34.88% below its all-time high of $23.07 billion, reached on March 31, 2019.
Performance
TAK quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TAK Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.7% | -2.0% |
| 3 y3 years | -5.2% | -5.8% |
| 5 y5 years | -16.8% | -20.2% |
TAK Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | +9.7% | -19.5% | +12.5% |
| 5 y | 5-year | -16.8% | +9.7% | -20.2% | +12.5% |
| alltime | all time | -27.3% | +761.5% | -34.9% | +367.1% |
TAK Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $15.02B(-10.4%) |
| Mar 2025 | $16.76B(+9.7%) | $16.76B(+25.6%) |
| Dec 2024 | - | $13.35B(-20.0%) |
| Sep 2024 | - | $16.69B(+8.9%) |
| Jun 2024 | - | $15.33B(+0.3%) |
| Mar 2024 | $15.28B(-18.0%) | $15.28B(-5.6%) |
| Dec 2023 | - | $16.19B(+2.0%) |
| Sep 2023 | - | $15.87B(-8.3%) |
| Jun 2023 | - | $17.31B(-7.2%) |
| Mar 2023 | $18.65B(+5.5%) | $18.65B(+10.0%) |
| Dec 2022 | - | $16.95B(+2.6%) |
| Sep 2022 | - | $16.52B(+3.6%) |
| Jun 2022 | - | $15.95B(-9.8%) |
| Mar 2022 | $17.68B(+10.2%) | $17.68B(+12.5%) |
| Dec 2021 | - | $15.71B(-8.6%) |
| Sep 2021 | - | $17.20B(+11.8%) |
| Jun 2021 | - | $15.38B(-4.2%) |
| Mar 2021 | $16.05B(-20.4%) | $16.05B(-8.2%) |
| Dec 2020 | - | $17.48B(+7.9%) |
| Sep 2020 | - | $16.20B(-14.0%) |
| Jun 2020 | - | $18.83B(-6.6%) |
| Mar 2020 | $20.16B(-12.6%) | $20.16B(+3.0%) |
| Dec 2019 | - | $19.58B(+29.4%) |
| Sep 2019 | - | $15.12B(-18.8%) |
| Jun 2019 | - | $18.62B(-19.3%) |
| Mar 2019 | $23.07B(+232.6%) | $23.07B(+190.3%) |
| Dec 2018 | - | $7.95B(+6.9%) |
| Sep 2018 | - | $7.43B(+12.2%) |
| Jun 2018 | - | $6.62B(-4.5%) |
| Mar 2018 | $6.93B(-43.4%) | $6.93B(-11.0%) |
| Dec 2017 | - | $7.80B(+4.6%) |
| Sep 2017 | - | $7.45B(-10.9%) |
| Jun 2017 | - | $8.36B(-31.8%) |
| Mar 2017 | $12.26B(+60.8%) | $12.26B(+49.3%) |
| Dec 2016 | - | $8.21B(+2.8%) |
| Sep 2016 | - | $7.99B(-0.4%) |
| Jun 2016 | - | $8.02B(+5.2%) |
| Mar 2016 | $7.63B(-10.0%) | $7.63B(-9.3%) |
| Dec 2015 | - | $8.41B(+2.1%) |
| Sep 2015 | - | $8.23B(-0.4%) |
| Jun 2015 | - | $8.26B(-2.6%) |
| Mar 2015 | $8.48B(+8.8%) | $8.48B(+21.3%) |
| Dec 2014 | - | $6.99B(-1.6%) |
| Sep 2014 | - | $7.10B(-2.8%) |
| Jun 2014 | - | $7.31B(-1.4%) |
| Mar 2014 | $7.79B(+15.6%) | $7.42B(+34.1%) |
| Dec 2013 | - | $5.53B(-0.8%) |
| Sep 2013 | - | $5.57B(+1.9%) |
| Jun 2013 | - | $5.47B(-16.1%) |
| Mar 2013 | $6.74B | $6.53B(-1.5%) |
| Dec 2012 | - | $6.62B(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $6.28B(-31.1%) |
| Jun 2012 | - | $9.10B(-0.3%) |
| Mar 2012 | $9.13B(+73.4%) | $9.13B(-31.6%) |
| Dec 2011 | - | $13.35B(+1.1%) |
| Sep 2011 | - | $13.20B(+173.7%) |
| Jun 2011 | - | $4.82B(-8.5%) |
| Mar 2011 | $5.27B(+14.9%) | $5.27B(+13.9%) |
| Dec 2010 | - | $4.62B(+2.9%) |
| Sep 2010 | - | $4.49B(+8.1%) |
| Jun 2010 | - | $4.16B(-9.3%) |
| Mar 2010 | $4.59B(-4.1%) | $4.59B(+0.1%) |
| Dec 2009 | - | $4.58B(-4.6%) |
| Sep 2009 | - | $4.80B(+4.6%) |
| Jun 2009 | - | $4.59B(-3.9%) |
| Mar 2009 | $4.78B(+11.0%) | $4.78B(+5.7%) |
| Dec 2008 | - | $4.52B(-3.4%) |
| Sep 2008 | - | $4.68B(+1.5%) |
| Jun 2008 | - | $4.61B(+7.0%) |
| Mar 2008 | $4.31B(+15.0%) | - |
| Mar 2008 | - | $4.31B(+14.2%) |
| Dec 2007 | - | $3.77B(-0.5%) |
| Sep 2007 | - | $3.79B(+11.2%) |
| Jun 2007 | - | $3.41B(-9.0%) |
| Mar 2007 | $3.75B(-9.5%) | - |
| Mar 2007 | - | $3.75B(+3.2%) |
| Dec 2006 | - | $3.63B(+3.9%) |
| Sep 2006 | - | $3.49B(-5.8%) |
| Jun 2006 | - | $3.71B(-10.4%) |
| Mar 2006 | $4.14B(+21.1%) | - |
| Mar 2006 | - | $4.14B(+12.8%) |
| Dec 2005 | - | $3.67B(-4.9%) |
| Sep 2005 | - | $3.86B(+12.5%) |
| Jun 2005 | - | $3.43B(+0.4%) |
| Mar 2005 | $3.42B(-4.1%) | - |
| Mar 2005 | - | $3.42B(-1.5%) |
| Dec 2004 | - | $3.47B(+6.3%) |
| Sep 2004 | - | $3.26B(+1.4%) |
| Jun 2004 | - | $3.22B |
| Mar 2004 | $3.56B(+22.5%) | - |
| Mar 2003 | $2.91B(+3.6%) | - |
| Mar 2002 | $2.81B(+1.7%) | - |
| Mar 2001 | $2.76B(-10.1%) | - |
| Mar 2000 | $3.07B(+30.4%) | - |
| Mar 1999 | $2.35B(-2.9%) | - |
| Mar 1998 | $2.42B(+2.7%) | - |
| Mar 1997 | $2.36B(-15.4%) | - |
| Mar 1996 | $2.79B(-12.3%) | - |
| Mar 1995 | $3.18B(+20.1%) | - |
| Mar 1994 | $2.65B(+22.1%) | - |
| Mar 1993 | $2.17B(+9.9%) | - |
| Mar 1992 | $1.98B(+1.6%) | - |
| Mar 1991 | $1.95B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total current liabilities?
- What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total current liabilities?
The current annual current liabilities of TAK is $16.76B
What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total current liabilities is $23.07B
What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
Over the past year, TAK annual total current liabilities has changed by +$1.48B (+9.67%)
What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
The current quarterly current liabilities of TAK is $15.02B
What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total current liabilities is $23.07B
What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
Over the past year, TAK quarterly total current liabilities has changed by -$304.99M (-1.99%)